A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
Physician-practice Based Cohort Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Japan
1 other identifier
observational
448
1 country
14
Brief Summary
The study aims to estimate the incidence of herpes zoster (HZ), proportion of postherpetic neuralgia (PHN) and the economic burden and impact on quality of life, in Japanese adults greater than or equal to sixty years of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2013
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2013
CompletedFirst Posted
Study publicly available on registry
June 10, 2013
CompletedStudy Start
First participant enrolled
June 29, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2015
CompletedJune 1, 2018
May 1, 2018
1.6 years
June 6, 2013
May 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Total number of HZ cases reported in the study area, overall and within a specific age-group and gender. The following age-groups will be considered: 60-69, 70-79 and ≥ 80 years of age.
Approximately 1 year
Occurrence of HZ-associated PHN pain, persisting between 90 and 270 days after the initial visit for this study.
Day 90 - Day 270
Secondary Outcomes (8)
Occurrence of HZ-associated hospitalisations.
Day 0 - Day 270
Occurrence of HZ-associated any pain, persisting between 0 and 270 days after the initial visit for this study.
Day 0 - Day 270
Anamnestic information, clinical parameters and complications related to HZ.
Day 0 - Day 270
Direct medical, direct non-medical and indirect costs related to HZ.
Day 0 - Day 90
Quality of life (QoL) assessment in HZ subjects.
Day 0 - Day 90
- +3 more secondary outcomes
Study Arms (1)
Prospective Group
Japanese adults, aged greater than or equal to sixty years, diagnosed with HZ.
Interventions
Eligibility Criteria
Japanese adults, male or female, greater than or equal to sixty years of age, presenting with HZ at the participating sites.
You may qualify if:
- Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.
- Written informed consent obtained from the subject.
- A male or female greater than or equal to sixty years of age, presenting with HZ at the time of enrollment.
- HZ diagnosis.
- Is the subject's first outpatient diagnosis for this HZ episode. OR
- Took place up to seven days prior to the initial visit for the present study. Note: Recurrent HZ cases may be enrolled as new cases based on the investigator's clinical practice.
You may not qualify if:
- Not applicable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
Study Sites (14)
GSK Investigational Site
Hokkaido, 084-0906, Japan
GSK Investigational Site
Hokkaido, 084-0909, Japan
GSK Investigational Site
Hokkaido, 084-0912, Japan
GSK Investigational Site
Hokkaido, 085-0014, Japan
GSK Investigational Site
Hokkaido, 085-0032, Japan
GSK Investigational Site
Hokkaido, 085-0036, Japan
GSK Investigational Site
Hokkaido, 085-0052, Japan
GSK Investigational Site
Hokkaido, 085-0057, Japan
GSK Investigational Site
Hokkaido, 085-0062, Japan
GSK Investigational Site
Hokkaido, 085-0063, Japan
GSK Investigational Site
Hokkaido, 085-0805, Japan
GSK Investigational Site
Hokkaido, 085-0813, Japan
GSK Investigational Site
Hokkaido, 085-0822, Japan
GSK Investigational Site
Hokkaido, 085-8533, Japan
Related Publications (3)
Mizukami A, Sato K, Adachi K, Matthews S, Holl K, Matsuki T, Kaise T, Curran D. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study. Clin Drug Investig. 2018 Jan;38(1):29-37. doi: 10.1007/s40261-017-0581-5.
PMID: 29086340DERIVEDNakamura H, Mizukami A, Adachi K, Matthews S, Holl K, Asano K, Watanabe A, Adachi R, Kiuchi M, Kobayashi K, Sato K, Matsuki T, Kaise T, Curran D. Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan. Drugs Real World Outcomes. 2017 Dec;4(4):187-198. doi: 10.1007/s40801-017-0119-4.
PMID: 28988331DERIVEDSato K, Adachi K, Nakamura H, Asano K, Watanabe A, Adachi R, Kiuchi M, Kobayashi K, Matsuki T, Kaise T, Gopala K, Holl K. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study. J Dermatol. 2017 Apr;44(4):414-422. doi: 10.1111/1346-8138.13639. Epub 2016 Dec 5.
PMID: 27917531DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2013
First Posted
June 10, 2013
Study Start
June 29, 2013
Primary Completion
February 4, 2015
Study Completion
February 4, 2015
Last Updated
June 1, 2018
Record last verified: 2018-05